ロード中...
Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study–Renal (CANVAS‐R): A randomized, placebo‐controlled trial
AIMS: The primary aim of the CANagliflozin cardioVascular Assessment Study‐Renal (CANVAS‐R) is to determine whether the favourable effects of inhibition of the sodium glucose co‐transporter 2 (SGLT2) on blood glucose, blood pressure and body weight are accompanied by protection against adverse renal...
保存先:
| 出版年: | Diabetes Obes Metab |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Blackwell Publishing Ltd
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5348724/ https://ncbi.nlm.nih.gov/pubmed/28120497 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12829 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|